These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 22806266)

  • 21. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
    Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
    Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes.
    Kamble B; Talreja S; Gupta A; Patil D; Pathak D; Moothedath I; Duraiswamy B
    Nanomedicine (Lond); 2013 Aug; 8(8):1295-305. PubMed ID: 23259778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: In-vitro characterization and in-vivo activity.
    Qumbar M; Ameeduzzafar ; Imam SS; Ali J; Ahmad J; Ali A
    Biomed Pharmacother; 2017 Sep; 93():255-266. PubMed ID: 28738502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery.
    Bayindir ZS; Yuksel N
    J Pharm Sci; 2010 Apr; 99(4):2049-60. PubMed ID: 19780133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced transdermal delivery of luteolin via non-ionic surfactant-based vesicle: quality evaluation and anti-arthritic assessment.
    Abidin L; Mujeeb M; Imam SS; Aqil M; Khurana D
    Drug Deliv; 2016; 23(3):1079-84. PubMed ID: 25116512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.
    Chen S; Hanning S; Falconer J; Locke M; Wen J
    Eur J Pharm Biopharm; 2019 Nov; 144():18-39. PubMed ID: 31446046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro Characterization and Release Studies of Combined Nonionic Surfactant-Based Vesicles for the Prolonged Delivery of an Immunosuppressant Model Drug.
    Rasul A; Imran Khan M; Ur Rehman M; Abbas G; Aslam N; Ahmad S; Abbas K; Akhtar Shah P; Iqbal M; Ahmed Al Subari AM; Shaheer T; Shah S
    Int J Nanomedicine; 2020; 15():7937-7949. PubMed ID: 33116510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS; Mortada ND; Mansour S; Hathout RM
    Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting.
    Ravouru N; Kondreddy P; Korakanchi D; Haritha M
    Curr Drug Discov Technol; 2013 Dec; 10(4):270-82. PubMed ID: 23863098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Collagen loaded nano-sized surfactant based dispersion for topical application: formulation development, characterization and safety study.
    Ahmad I; Akhter S; Ahmad MZ; Shamim M; Rizvi MA; Khar RK; Ahmad FJ
    Pharm Dev Technol; 2014 Jun; 19(4):460-7. PubMed ID: 23675949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of novel diolein-niosomes for cutaneous delivery of tretinoin: influence of formulation and in vitro assessment.
    Manca ML; Manconi M; Nacher A; Carbone C; Valenti D; Maccioni AM; Sinico C; Fadda AM
    Int J Pharm; 2014 Dec; 477(1-2):176-86. PubMed ID: 25455770
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermal and 31P-NMR studies to elucidate sumatriptan succinate entrapment behavior in phosphatidylcholine/cholesterol liposomes. Comparative 31P-NMR analysis on negatively and positively-charged liposomes.
    Villasmil-Sánchez S; Rabasco AM; González-Rodríguez ML
    Colloids Surf B Biointerfaces; 2013 May; 105():14-23. PubMed ID: 23352939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK; Palei NN
    Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models.
    Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S
    Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro characterisation of Span 65 niosomal formulations containing proteins.
    Haj-Ahmad RR; Elkordy AA; Chaw CS
    Curr Drug Deliv; 2015; 12(5):628-39. PubMed ID: 25963305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: Formulation development, in vitro and in vivo evaluation of skin deposition.
    Kassem AA; Abd El-Alim SH; Asfour MH
    Int J Pharm; 2017 Jan; 517(1-2):256-268. PubMed ID: 27956194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery.
    Varshosaz J; Pardakhty A; Hajhashemi VI; Najafabadi AR
    Drug Deliv; 2003; 10(4):251-62. PubMed ID: 14612341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
    Tavano L; Alfano P; Muzzalupo R; de Cindio B
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alkyl glucopyranoside-based niosomes containing methotrexate for pharmaceutical applications: evaluation of physico-chemical and biological properties.
    Muzzalupo R; Tavano L; La Mesa C
    Int J Pharm; 2013 Dec; 458(1):224-9. PubMed ID: 24060370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin.
    Manconi M; Sinico C; Valenti D; Lai F; Fadda AM
    Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.